Skip to main content
. 2014 Aug 12;2(6):1125–1134. doi: 10.3892/mco.2014.386

Figure 3.

Figure 3

Forest plot of the 11 studies on adjuvant interferon therapy for hepatitis C virus associated with hepatocellular carcinoma patients following curative therapy. (A) overall mortality; (B) 1-year early recurrence; (C) 2-year early recurrence; (D) late recurrence. CI, confidence interval.